Drug Profile


Alternative Names: AT-GD-459; ATX-GD-459; ATX-GD-59

Latest Information Update: 28 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Apitope Technology
  • Class Peptide vaccines; Peptides; Vaccines
  • Mechanism of Action Immunomodulators; Interleukin 10 stimulants; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Graves' disease

Most Recent Events

  • 26 Oct 2016 Phase-I clinical trials in Graves' disease in United Kingdom (Parenteral)
  • 19 Jun 2014 Preclinical trials in Graves' disease in United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top